Dolby Laboratories Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Dolby Laboratories stock.
View analyst ratings for Dolby Laboratories or view top-rated stocks.

Wall Street analysts have given Dolby Laboratories a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Dolby Laboratories wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Dolby Laboratories saw a increase in short interest in February. As of February 12th, there was short interest totaling 796,600 shares, an increase of 101.7% from the January 28th total of 395,000 shares. Based on an average daily trading volume, of 494,700 shares, the short-interest ratio is currently 1.6 days.
View Dolby Laboratories' Short Interest.

Dolby Laboratories is scheduled to release its next quarterly earnings announcement on Monday, May 3rd 2021.
View our earnings forecast for Dolby Laboratories.

Dolby Laboratories, Inc. (NYSE:DLB) issued its quarterly earnings results on Thursday, January, 28th. The electronics maker reported $1.48 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.86 by $0.62. The electronics maker earned $389.87 million during the quarter, compared to the consensus estimate of $345.33 million. Dolby Laboratories had a trailing twelve-month return on equity of 9.89% and a net margin of 19.91%. The company's revenue was up 33.6% on a year-over-year basis. During the same period last year, the company earned $0.64 EPS.
View Dolby Laboratories' earnings history.

Dolby Laboratories' stock was trading at $60.23 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DLB stock has increased by 62.1% and is now trading at $97.63.
View which stocks have been most impacted by COVID-19.

Dolby Laboratories announced a quarterly dividend on Friday, January 29th. Investors of record on Tuesday, February 9th will be paid a dividend of $0.22 per share on Friday, February 19th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date is Monday, February 8th.
View Dolby Laboratories' dividend history.

Dolby Laboratories pays an annual dividend of $0.88 per share and currently has a dividend yield of 0.91%. Dolby Laboratories does not yet have a strock track record of dividend growth. The dividend payout ratio of Dolby Laboratories is 38.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 30.34% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.
View Dolby Laboratories' dividend history.

Dolby Laboratories updated its second quarter earnings guidance on Thursday, January, 28th. The company provided earnings per share (EPS) guidance of $0.57-0.72 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.62. The company issued revenue guidance of $280-310 million, compared to the consensus revenue estimate of $290.10 million.

4 brokers have issued 12 month price targets for Dolby Laboratories' shares. Their forecasts range from $65.00 to $89.00. On average, they expect Dolby Laboratories' stock price to reach $79.00 in the next twelve months. This suggests that the stock has a possible downside of 19.1%.
View analysts' price targets for Dolby Laboratories or view top-rated stocks among Wall Street analysts.

253 employees have rated Dolby Laboratories CEO Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among Dolby Laboratories' employees.

Some companies that are related to Dolby Laboratories include Amphenol (APH), Corning (GLW), Littelfuse (LFUS), Vishay Intertechnology (VSH) and Rogers (ROG).
View all of DLB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (3.67%), Clearbridge Investments LLC (3.59%), Janus Henderson Group PLC (3.25%), Jackson Square Partners LLC (2.13%), Mackenzie Financial Corp (2.11%) and Ceredex Value Advisors LLC (1.29%). Company insiders that own Dolby Laboratories stock include Avadis Tevanian, Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay and Todd Pendleton.
View institutional ownership trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Alliancebernstein L.P., Renaissance Technologies LLC, Janus Henderson Group PLC, Trigran Investments Inc., Schroder Investment Management Group, Schroder Investment Management Group, and Clearbridge Investments LLC. Company insiders that have sold Dolby Laboratories company stock in the last year include Avadis Tevanian, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay, and Todd Pendleton.
View insider buying and selling activity for Dolby Laboratories or view top insider-selling stocks.

DLB stock was acquired by a variety of institutional investors in the last quarter, including Jackson Square Partners LLC, Victory Capital Management Inc., Assenagon Asset Management S.A., Sei Investments Co., BlackRock Inc., Sumitomo Mitsui Trust Holdings Inc., Fiera Capital Corp, and Tudor Investment Corp Et Al.
View insider buying and selling activity for Dolby Laboratories or or view top insider-buying stocks.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DLB stock can currently be purchased for approximately $97.63.

Dolby Laboratories has a market capitalization of $9.92 billion and generates $1.16 billion in revenue each year. The electronics maker earns $231.36 million in net income (profit) each year or $2.30 on an earnings per share basis.

Dolby Laboratories employs 2,289 workers across the globe.

The official website for Dolby Laboratories is www.dolby.com.

Dolby Laboratories is headquartered at 1275 MARKET STREET, SAN FRANCISCO CA, 94103.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]